Literature DB >> 22829289

Expression signatures of intragenic miRNAs and their corresponding host genes in myeloid leukemia cells.

Jing Wang1, Guangxin Xiang, Ke Zhang, Yuxiang Zhou.   

Abstract

MicroRNAs (miRNAs) are a class of small non-coding RNAs involved in gene regulation. Approximately half of miRNAs are located within known genes and called intragenic miRNAs. 408 human intragenic miRNAs and their corresponding host genes were analyzed for genomic organization and functional characterization. Using quantitative real-time PCR, the expression levels of a subset of intragenic miRNAs and their host genes were examined in diverse myeloid leukemia cell lines, and their regulation in response to pharmacological stimuli was also evaluated. Expression of miR-22 strongly correlated with both myeloid leukemia subtypes and the expression of its host gene C17orf91 (p < 0.05). The latter was absent in hematopoietic progenitors but abundant in erythroid and monocytic lineages. These results demonstrated that the expression signatures of miR-22 and C17orf91 are associated with developmental lineages and specific leukemia subtypes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22829289     DOI: 10.1007/s10529-012-1018-0

Source DB:  PubMed          Journal:  Biotechnol Lett        ISSN: 0141-5492            Impact factor:   2.461


  7 in total

1.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.

Authors:  Su Jung Song; Keisuke Ito; Ugo Ala; Lev Kats; Kaitlyn Webster; Su Ming Sun; Mojca Jongen-Lavrencic; Katia Manova-Todorova; Julie Teruya-Feldstein; David E Avigan; Ruud Delwel; Pier Paolo Pandolfi
Journal:  Cell Stem Cell       Date:  2013-07-03       Impact factor: 24.633

Review 2.  MicroRNAs as biomarkers in leukemia.

Authors:  Xinxin Wang; Baohua Zhu; Zunnan Huang; Liyong Chen; Zhiwei He; Hua Zhang
Journal:  Stem Cell Investig       Date:  2014-05-27

3.  Long noncoding RNA C17orf91 is a potential prognostic marker and functions as an oncogene in ovarian cancer.

Authors:  Jun Li; Hailin Yu; Meili Xi; Xin Lu
Journal:  J Ovarian Res       Date:  2016-08-17       Impact factor: 4.234

Review 4.  Emerging impact of the long noncoding RNA MIR22HG on proliferation and apoptosis in multiple human cancers.

Authors:  Le Zhang; Cuixia Li; Xiulan Su
Journal:  J Exp Clin Cancer Res       Date:  2020-12-03

5.  Identification and Functional Characterization of Long Non-coding RNA MIR22HG as a Tumor Suppressor for Hepatocellular Carcinoma.

Authors:  Dong-Yan Zhang; Xue-Jing Zou; Chuan-Hui Cao; Ting Zhang; Ling Lei; Xiao-Long Qi; Li Liu; De-Hua Wu
Journal:  Theranostics       Date:  2018-06-13       Impact factor: 11.556

6.  Intragenic MicroRNAs Autoregulate Their Host Genes in Both Direct and Indirect Ways-A Cross-Species Analysis.

Authors:  Maximilian Zeidler; Alexander Hüttenhofer; Michaela Kress; Kai K Kummer
Journal:  Cells       Date:  2020-01-17       Impact factor: 6.600

7.  Interfering with long non-coding RNA MIR22HG processing inhibits glioblastoma progression through suppression of Wnt/β-catenin signalling.

Authors:  Mingzhi Han; Shuai Wang; Sabrina Fritah; Xu Wang; Wenjing Zhou; Ning Yang; Shilei Ni; Bin Huang; Anjing Chen; Gang Li; Hrvoje Miletic; Frits Thorsen; Rolf Bjerkvig; Xingang Li; Jian Wang
Journal:  Brain       Date:  2020-02-01       Impact factor: 13.501

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.